Pharmaceutical and biotech stocks plummeted today as President-elect Donald Trump said he’d force the industry to bid for government business in order to save the government billions of dollars. He also discussed making it easier to import cheaper drugs in his first formal news conference since the Nov. 8 election.
By Paolo Palazzi-Xirinachs
Wednesday, January 11, 2017
The S&P 500 healthcare index reversed course following Trump's remarks and fell as much as 1.9%. After paring losses it was still down 1.2% and on track for its worst day since Nov. 22. The Nasdaq biotechnology index sank 3.1% and was on track for its worst day in three months. The pullback ended a six-day winning streak for both indexes.
The drug industry had been betting that Trump would be good for business - drug and biotech stocks were up since his election - but it now appears he may take up the banner Democrats carried during the campaign and lock onto drug prices as a populist issue that hits many Americans’ wallets.
The Dow Jones Industrial Average was up 63.87 points, or 0.32%, to 19,919.4, the S&P 500 had gained 0.93 points, or 0.040989%, to 2,269.83 and the Nasdaq Composite had dropped 8.06 points, or 0.15%, to 5,543.76.The CBOE Volatility index, also called Wall Street's "fear gauge", spiked as much as 6.4% before creeping back and was last was up 1%.
The PEOUTS has been tough on businesses that could take advantage of the USA - healthcare, auto makers, any exporter, anyone who did a corporate inversion, pharma, defense contractors and IT suppliers, sometimes hurting a company's bottom stock value with a single tweet. But traders should get used to White House headlines and tweets moving sectors and stocks. This is the new norm.
Meanwhile, most of Washington and the press today was equallty transfixed and trying to keep track of multiple simultaneous Senate confirmation hearings for Trump's cabinet, and Trump's first press conference in 6 months.
Big US companies start reporting fourth-quarter earnings this week. On Friday, JPMorgan Chase, Wells Fargo, and Bank of America will release their results.
This information has been prepared by Nadex, a trading name of North American Derivatives Exchange, Inc., prepared by independent third parties contracted by Nadex or reproduced form third party news agencies. In addition to the disclaimer below, the material on this page does not contain an offer of, or solicitation for, a transaction in any financial instrument. Nadex accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.